Inflation Reduction Act’s Drug Price Negotiation Provisions – What Now?

In July, the Centers for Medicare & Medicaid Services made significant headway in its implementation of the drug pricing provisions of the Inflation Reduction Act (IRA).

How can stakeholders respond to, implement, and comply with all these new provisions? On this episode, hear from special guest Sylvia Yu, Vice President and Senior Counsel of Federal Programs at PhRMA.

Sylvia and Epstein Becker Green attorneys Connie Wilkinson and Alexis Boaz discuss the recent updates on the quickly moving implementation of the drug pricing provisions under the IRA and the industry’s response.

Event Date: Tuesday, August 1, 2023

Event Webpage (Available for subscribers only)

Category(s): Health Policy and Regulatory, Pharmaceutical

Contact Speaker / Organization (Available for subscribers only)